Towards the Discovery of Predictive Biomarkers for Outcomes in Lupus Nephritis

致力于发现狼疮性肾炎预后的预测生物标志物

• 批准号: 491017
• 负责人: Whittall-Garcia Laura
• 金额: $ 9.83万
• 依托单位: University Health Network (Toronto)
• 依托单位国家: 加拿大
• 项目类别: Fellowship Programs
• 财政年份: 2023
• 资助国家: 加拿大
• 起止时间: 2023-05-01 至 2026-05-01
• 项目状态: 未结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=491017&lang=en
• 关键词: Biomarkers; Imaging Mass Cytometry; Lupus Nephritis; Systemic Lupus Erythematosus; Translational Research; Treatment Outcomes

Kidney disease, called Lupus Nephritis, is frequently seen in lupus, occurring in up to 65% of patients. It is highly variable in its severity and response to therapy, with up to 30% of patients failing to respond to treatment resulting in decreased kidne

肾脏疾病，称为狼疮性肾炎，常见于狼疮，发生率高达 65%。它的严重程度和对治疗的反应差异很大，高达 30% 的患者对治疗没有反应，导致肾功能下降